Tianjin TEDA Biomedical Engineering Co Ltd 2020 AR2
The report details the financial and sustainability performance of Tianjin TEDA Biomedical Engineering Company Limited for the fiscal year 2020. Despite challenges from the COVID-19 pandemic, the company achieved a turnover of RMB 369,355,184, representing a 2.96% increase year-on-year. The compound fertilizer business segment realized notable improvements, including intelligent upgrades of manufacturing processes at its subsidiary Guangdong Fulilong to reduce energy consumption. Additionally, the company expanded its elderly care and health care services under an asset-light model, including the promotion of assistive equipment rental services in Shanghai.
Company: Tianjin TEDA Biomedical Engineering Co Ltd
Sector: Materials
Country: China
Year: 2020
Type: AR2
Pages: 164
Tianjin TEDA Biomedical Engineering Co Ltd
Annual Report
The report details the financial and sustainability performance of Tianjin TEDA Biomedical Engineering Company Limited for the fiscal year 2020. Despite challenges from the COVID-19 pandemic, the company achieved a turnover of RMB 369,355,184, representing a 2.96% increase year-on-year. The compound fertilizer business segment realized notable improvements, including intelligent upgrades of manufacturing processes at its subsidiary Guangdong Fulilong to reduce energy consumption. Additionally, the company expanded its elderly care and health care services under an asset-light model, including the promotion of assistive equipment rental services in Shanghai.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Workplace Fatalities
Employees